Association Between Testosterone Levels and COPD Severity (COPDTESTO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02824809
Recruitment Status : Unknown
Verified July 2016 by Horacio Matias Castro, Hospital Italiano de Buenos Aires. Recruitment status was: Recruiting
First Posted : July 7, 2016
Last Update Posted : July 7, 2016
Hospital Italiano de Buenos Aires
Asociacion Argentina Medicina Respiratoria (AAMR)
Information provided by (Responsible Party):
Horacio Matias Castro, Hospital Italiano de Buenos Aires
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
45 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Outpatients with stable COPD that consult in a tertiary academic teaching hospital in Buenos Aires, Argentina
Adults Men ≥ 45 years
COPD defined according to clinical diagnosis and spirometry American thoracic society ( ATS) criteria
Stable COPD without recent acute exacerbation (less than 2 weeks)
Refusal to participate or informed consent process
Those who are under treatment with testosterone replacement or anti-androgens